id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
ajlm-2018	Okunorobo, Mercy N.; Nnamah, Nwakasi K.; Ude, Ugomma A.; Ude, Enyioma A.	Lipids and apolipoproteins C-III and E among treatment-naïve and treatment-experienced persons with HIV in Nigeria	2023		.htm	text/html	4591	270	45	Previous studies conducted in Ethopia in 2018 and Uganda between 2011 to 2014 have reported hypertension to be highly prevalent among HIV patients on ART treatment.23,24,25,26 HIV patients on ART are highly susceptible to developing hypertension compared to HIV-negative persons. The use of antiretroviral therapy (ART) in the management of HIV has improved the life expectancy of persons living with HIV4 but has also been associated with an increased risk of metabolic abnormalities, including dyslipidaemia and cardiovascular death.5,6,7 A higher burden of cardiovascular disease has been reported among HIV patients on highly active antiretroviral therapy treatment compared to highly active antiretroviral therapy-naïve patients.8 Dyslipidaemia refers to abnormal plasma lipid concentrations, including elevated plasma total cholesterol, low-density lipoprotein cholesterol (LDL-C), triglycerides, and reduced high-density lipoprotein cholesterol (HDL-C).	cache/ajlm-2018.htm	txt/ajlm-2018.txt